Human receptor tyrosine kinase, kdr
CA 2293723 A1 · Owner: Thomas, Kenneth A. · Inventors: Kendall, Richard L.; Tebben, Andrew; Thomas, Kenneth A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An isolated nucleic acid molecule encoding a novel human receptor type tyrosine kinase gene, KDR, is disclosed. The isolation of this KDR cDNA sequence results in disclosure of purified forms of human KDR protein recombinant vectors and recombinant hosts which express human KDR.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 17, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 17, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.